Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 22210082)

1.

Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes.

Rodriguez FJ, Stratakis CA, Evans DG.

Acta Neuropathol. 2012 Mar;123(3):349-67. doi: 10.1007/s00401-011-0935-7. Epub 2011 Dec 31. Review.

2.

Neurofibromatosis.

Korf BR.

Handb Clin Neurol. 2013;111:333-40. doi: 10.1016/B978-0-444-52891-9.00039-7. Review.

PMID:
23622184
3.

Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Carroll SL.

Acta Neuropathol. 2012 Mar;123(3):321-48. doi: 10.1007/s00401-011-0928-6. Epub 2011 Dec 11. Review.

4.

CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.

Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, Gutmann DH, Hanemann CO, Hennigan R, Huson S, Ingram D, Kissil J, Korf BR, Legius E, Packer RJ, McClatchey AI, McCormick F, North K, Pehrsson M, Plotkin SR, Ramesh V, Ratner N, Schirmer S, Sherman L, Schorry E, Stevenson D, Stewart DR, Ullrich N, Bakker AC, Morrison H.

Am J Med Genet A. 2014 Mar;164A(3):563-78. doi: 10.1002/ajmg.a.36312. Epub 2014 Jan 17.

5.

Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.

Brossier NM, Carroll SL.

Brain Res Bull. 2012 May 1;88(1):58-71. doi: 10.1016/j.brainresbull.2011.08.005. Epub 2011 Aug 10. Review.

6.

The Neurofibromatoses. Part 1: NF1.

Lu-Emerson C, Plotkin SR.

Rev Neurol Dis. 2009 Spring;6(2):E47-53. Review.

PMID:
19587630
7.

The neurofibromatoses. Part 2: NF2 and schwannomatosis.

Lu-Emerson C, Plotkin SR.

Rev Neurol Dis. 2009 Summer;6(3):E81-6. Review.

PMID:
19898272
8.

[Molecular genetics of familial tumour syndromes of the central nervous system].

Murnyák B, Szepesi R, Hortobágyi T.

Orv Hetil. 2015 Feb 1;156(5):171-7. doi: 10.1556/OH.2015.30092. Review. Hungarian.

PMID:
25618858
9.

Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJ, Hunter-Schaedle K, Kalpana GV, Korf B, Messiaen L, Papi L, Ratner N, Sherman LS, Smith MJ, Stemmer-Rachamimov AO, Vitte J, Giovannini M.

Am J Med Genet A. 2013 Mar;161A(3):405-16. doi: 10.1002/ajmg.a.35760. Epub 2013 Feb 7.

10.

The neurofibromatoses: hereditary predisposition to multiple peripheral nerve tumors.

Brooks DG.

Neurosurg Clin N Am. 2004 Apr;15(2):145-55. Review.

PMID:
15177314
11.

SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?

Rizzo D, Fréneaux P, Brisse H, Louvrier C, Lequin D, Nicolas A, Ranchère D, Verkarre V, Jouvet A, Dufour C, Edan C, Stéphan JL, Orbach D, Sarnacki S, Pierron G, Parfait B, Peuchmaur M, Delattre O, Bourdeaut F.

Am J Surg Pathol. 2012 Jul;36(7):964-72. doi: 10.1097/PAS.0b013e31825798f1.

PMID:
22614000
12.

Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis. Case report.

Spinner RJ, Scheithauer BW, Perry A, Amrami KK, Emnett R, Gutmann DH.

J Neurosurg. 2007 Aug;107(2):435-9.

PMID:
17695403
13.

Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.

Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L.

Hum Mutat. 2008 Feb;29(2):227-31.

PMID:
18072270
14.

Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.

Smith MJ, Wallace AJ, Bowers NL, Rustad CF, Woods CG, Leschziner GD, Ferner RE, Evans DG.

Neurogenetics. 2012 May;13(2):141-5. doi: 10.1007/s10048-012-0319-8. Epub 2012 Mar 22.

PMID:
22434358
15.

Neurofibromatosis-associated nerve sheath tumors. Case report and review of the literature.

Murovic JA, Kim DH, Kline DG.

Neurosurg Focus. 2006 Jan 15;20(1):E1. Review.

PMID:
16459989
16.

Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.

Stratakis CA, Kirschner LS, Carney JA.

J Clin Endocrinol Metab. 2001 Sep;86(9):4041-6. Review.

PMID:
11549623
17.

Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.

Harder A, Wesemann M, Hagel C, Schittenhelm J, Fischer S, Tatagiba M, Nagel C, Jeibmann A, Bohring A, Mautner VF, Paulus W.

Am J Surg Pathol. 2012 May;36(5):702-9. doi: 10.1097/PAS.0b013e31824d3155.

PMID:
22446939
18.

The neurofibromatoses.

Ferner RE.

Pract Neurol. 2010 Apr;10(2):82-93. doi: 10.1136/jnnp.2010.206532. Review.

PMID:
20308235
19.

A superficial form of malignant peripheral nerve sheath tumour associated with segmental neurofibromatosis.

Li K, Won CH, Moon SE.

Acta Derm Venereol. 2005;85(6):540-1. No abstract available.

20.

SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.

Rousseau G, Noguchi T, Bourdon V, Sobol H, Olschwang S.

BMC Neurol. 2011 Jan 24;11:9. doi: 10.1186/1471-2377-11-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk